- Home
- SEB vs RARE Comparison
SEB vs RARE Comparison
Compare SEB & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEB
- RARE
- Stock Information
- Founded
- SEB 1918
- RARE 2010
- Country
- SEB United States
- RARE United States
- Employees
- SEB N/A
- RARE N/A
- Industry
- SEB Farming/Seeds/Milling
- RARE Biotechnology: Pharmaceutical Preparations
- Sector
- SEB Industrials
- RARE Health Care
- Exchange
- SEB Nasdaq
- RARE Nasdaq
- Market Cap
- SEB 2.5B
- RARE 2.6B
- IPO Year
- SEB N/A
- RARE 2014
- Fundamental
- Price
- SEB $3,188.99
- RARE $28.44
- Analyst Decision
- SEB
- RARE Strong Buy
- Analyst Count
- SEB 0
- RARE 16
- Target Price
- SEB N/A
- RARE $86.94
- AVG Volume (30 Days)
- SEB 1.6K
- RARE 3.3M
- Earning Date
- SEB 07-29-2025
- RARE 08-05-2025
- Dividend Yield
- SEB 0.28%
- RARE N/A
- EPS Growth
- SEB N/A
- RARE N/A
- EPS
- SEB 143.20
- RARE N/A
- Revenue
- SEB $9,496,000,000.00
- RARE $590,689,000.00
- Revenue This Year
- SEB N/A
- RARE $18.70
- Revenue Next Year
- SEB N/A
- RARE $26.76
- P/E Ratio
- SEB $22.12
- RARE N/A
- Revenue Growth
- SEB 4.70
- RARE 33.46
- 52 Week Low
- SEB $2,365.00
- RARE $25.81
- 52 Week High
- SEB $3,300.00
- RARE $60.37
- Technical
- Relative Strength Index (RSI)
- SEB 69.08
- RARE 40.47
- Support Level
- SEB $3,081.22
- RARE $26.85
- Resistance Level
- SEB $3,262.21
- RARE $28.48
- Average True Range (ATR)
- SEB 76.25
- RARE 1.23
- MACD
- SEB 2.06
- RARE 0.19
- Stochastic Oscillator
- SEB 73.10
- RARE 74.08
About SEB Seaboard Corporation
Seaboard Corp is a diversified group of companies that operate in agricultural, energy, and ocean transport businesses. The company is engaged in hog production, biofuel production, and pork processing in the United States; commodity trading and grain processing in Africa and South America; cargo shipping services in the U.S., Caribbean and Central and South America; sugar and alcohol production in Argentina; and electric power generation in the Dominican Republic. It also has an equity method investment in Butterball, LLC, a producer and processor of turkey products. The group's operating segments are; pork, commodity trading and milling, marine, liquid fuels, power, turkey, and others. It operates in 45 countries, with a concentration in the Caribbean, Central and South American region.
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.